A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors
Clinical trial NCT00985374 · TERMINATED
Trial details
- NCT number
- NCT00985374
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2013-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.